Speakers

Panelists

Marty Makary, MD, MPH

27th Commissioner of the FDA

Dennis Purcell

Founder and Senior Advisor
Aisling Capital

Ginger Constantine, MD

CEO
Pleo Pharma

Ketan Patel, MD

Partner
F-Prime Capital

Lauren Leanza

Vice President, Market Access – Cardiometabolic Health
Eli Lilly and Company

Chong Xu

Partner
F-Prime Capital

Raj Kannan

CEO
Alveus Therapeutics

Paul Titchenell, PhD

Executive Director – Head of Metabolic Physiology, Cardiometabolic Research
Eli Lilly and Company

Zev Sunleaf

Vice President, Technology Transfer, Commercialization & Research Contracts
Children’s Hospital of Philadelphia

Hugh Davis, PhD

Chief Operating Officer & President
Aclaris Therapeutics

Robert McGrath, PhD

Executive Director of Business Development
Yale Ventures

Subin Baral

Partner, Global Deals Leader – Life Sciences Transactions
EY

Annie, Matt and Charlotte Devine

Patient Perspective

Marissa Perman, MD

Pediatric Dermatologist, Section Chief of Dermatology and Director of the Epidermolysis Bullosa Multidisciplinary Clinic
Children’s Hospital of Philadelphia

Richard Snyder, MD

Executive Vice President & Chief Operating Officer
Independence Blue Cross

Andrew Hawkins

Senior Director, U.S. Policy & Research, U.S. Policy & Government Affairs
Bristol Myers Squibb

Stephen Simpson

Retired Partner
EY

Rebecca Guzman

Partner
Duane Morris

Joanne Soslow

Partner
Morgan Lewis

Ryan Udell

Partner
Ballard Spahr

Mike Goodman

Shareholder
Brownstein

James Bauersmith

Vice President, Translational Science
UPMC Enterprises

Rachael Bushey

Life Sciences Partner & Co-chair, Philadelphia Office
Goodwin

Reverse Pitch Presenters

Bryan Hansen, PhD

Senior Director of External Innovation
Johnson&Johnson

Alyssa Johnson

Senior Director, Business Development
Harmony Biosciences

Alex Tullman

Partner
NeXeption Capital

Frank Yohe

Global Business Head of Natural Materials
dsm-firmenich

John Sanders

Director, Enabling Technologies Search and Evaluation, Business Development & Licensing
Merck

Tom Wilton

SVP Innovation Ventures
Children’s Hospital of Philadelphia

Scott Morley

Senior Director, Office of Industry and Economic Partnerships
University of Pittsburgh

Katie Reuther, PhD

Executive Director, Penn Health-Tech Practice Professor in Bioengineering
University of Pennsylvania

Melissa Kelly, PhD

Deputy Managing Director
Penn Center for Innovation

Sue Rhoades

Assistant Vice Provost, Applied Innovation
Drexel University

Ketan Mehta

Senior Director, Search & Evaluation (Internal Medicine), Worldwide Business Development
Pfizer

Brian Imszennik

Director, Venture Investments – New Company Creation
Johnson & Johnson – JJDC

Jeannie Rojas

Senior Director, Worldwide Business Development
GSK

Sean Hobson

Senior Manager, Corporate Development
Teleflex

Jonathan Andrews

Director, Business Development
B. Braun Medical

Steve Kulp

Chief Operating Officer & Co-Founder
Valenscion Holdings

Jeffrey Alexander

Site Head
Lilly Gateway Labs – Philadelphia

Thank you to our 2026 event sponsors

Interested in sponsoring Life Sciences Future? Please contact Gabi Forgione (gforgione@lifesciencespa.org) for sponsorship inquiries.

Get Updates
from LSPA

Stay up-to-date on the latest news and events from Life Sciences PA, insights from the life sciences industry,  and so much more!

LifeSciencesPA_logo

Life Sciences Pennsylvania was founded in 1989 by a biotech scientist at Penn State University.  Today it has grown to represent the entire life sciences industry – biotechnology and diagnostic companies, medical device companies, pharmaceutical companies, investment organizations, research institutions, and myriad service industries that support the life sciences in Pennsylvania.

Reach Out to us

411 Swedeland Road
Suite 23-1080
King of Prussia, PA 19406